Bùláng

Shanghai Biolang Biotechnology is a Chinese life sciences company established in 2004 that specializes in the research, development, and manufacturing of innovative drugs, pharmaceutical intermediates, and active pharmaceutical ingredients (APIs). The company operates a significant R&D center in Wuhan's Optics Valley Bio-City and maintains cGMP-compliant production facilities that have undergone FDA review. Its product portfolio includes a wide range of steroids, selective androgen receptor modulators (SARMs), and peptides, alongside intermediates for major therapeutic areas such as diabetes. Shanghai Biolang provides custom synthesis and contract manufacturing services to global pharmaceutical partners while advancing its own internal development programs.